US pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year, to target weight loss market

This announcement was made by CEO David Ricks in an exclusive interview with Business Today on Wednesday.

Related Keywords

India ,United Kingdom ,United States ,American ,David Ricks ,Eli Lilly ,Orexigen Therapeutics ,Roche Pharmaceuticals ,National Family Health ,Novo Nordisk ,International Diabetes Federation ,Vivus Pharmaceuticals ,Business Today ,Alongside Mounjaro ,New Product ,International Diabetes ,Quot Eli Lilly ,Mounjaro ,Diabetes Medication ,Indian Market ,Eo David Ricks ,Regulatory Approval ,Zepbound ,Weight Loss Drug ,Pharmaceutical Companies ,Increase In Revenue ,Fatty Liver Disease ,Igh Diabetes Rate In India ,Obesity In India ,Nti Obesity Market ,Anti Obesity Drugs ,Rivus Pharmaceuticals ,Rexigen Therapeutics Quot ,